These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35936768)

  • 1. Diagnostic value of striatal
    Liu XL; Liu SY; Barret O; Tamagnan GD; Qiao HW; Song TB; Lu J; Chan P
    Front Aging Neurosci; 2022; 14():931015. PubMed ID: 35936768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
    Lin KJ; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Hsiao IT
    PLoS One; 2013; 8(9):e75952. PubMed ID: 24098749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements.
    Lin KJ; Lin WY; Hsieh CJ; Weng YH; Wey SP; Lu CS; Skovronsky D; Yen TC; Chang CJ; Kung MP; Hsiao IT
    Nucl Med Biol; 2011 Nov; 38(8):1149-55. PubMed ID: 21831650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multi-Atlas-Based [18F]9-Fluoropropyl-(+)-Dihydrotetrabenazine Positron Emission Tomography Image Segmentation Method for Parkinson's Disease Quantification.
    Pan Y; Liu S; Zeng Y; Ye C; Qiao H; Song T; Lv H; Chan P; Lu J; Ma T
    Front Aging Neurosci; 2022; 14():902169. PubMed ID: 35769601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-human study of D6-[
    Zhao R; Chen J; Ye T; Chu J; Li J; Zhang Y; Xu S; Liu S; Chen L; Ploessl K; Alexoff D; Kung HF; Zhu L; Wang X
    EJNMMI Radiopharm Chem; 2024 Oct; 9(1):71. PubMed ID: 39412702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and gender effects on striatal dopamine transporter density and cerebral perfusion in individuals with non-degenerative parkinsonism: a dual-phase
    Kim JY; Kang SY; Moon BS; Kim BS; Jeong JH; Yoon HJ
    EJNMMI Res; 2024 Jul; 14(1):65. PubMed ID: 39017925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging with [
    Tang J; Xu Y; Liu C; Fang Y; Cao S; Zhao C; Huang H; Zou M; Chen Z
    Nucl Med Biol; 2020; 90-91():1-9. PubMed ID: 32861175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
    Hsiao IT; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Lin KJ
    JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification and discriminative power of
    Delva A; Van Weehaeghe D; van Aalst J; Ceccarini J; Koole M; Baete K; Nuyts J; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP
    PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative study of
    Jung Lung H; Weng YH; Wen MC; Hsiao IT; Lin KJ
    Sci Rep; 2018 Oct; 8(1):16027. PubMed ID: 30375444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of
    Li S; Lu W; Yan S; Song T; Zhang C; Yang C; Lu J
    Quant Imaging Med Surg; 2024 Oct; 14(10):7406-7419. PubMed ID: 39429607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain microglia activation and peripheral adaptive immunity in Parkinson's disease: a multimodal PET study.
    Liu SY; Qiao HW; Song TB; Liu XL; Yao YX; Zhao CS; Barret O; Xu SL; Cai YN; Tamagnan GD; Sossi V; Lu J; Chan P
    J Neuroinflammation; 2022 Aug; 19(1):209. PubMed ID: 36038917
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Huang AQ; Liu SY; Barret O; Qiao HW; Tamagnan GD; Liu XL; Fan CC; Li Z; Lu J; Chan P; Xu EH
    Parkinsonism Relat Disord; 2024 Mar; 120():105979. PubMed ID: 38241952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages.
    Wang J; Zuo CT; Jiang YP; Guan YH; Chen ZP; Xiang JD; Yang LQ; Ding ZT; Wu JJ; Su HL
    J Neurol; 2007 Feb; 254(2):185-90. PubMed ID: 17334953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease.
    Yang Y; Cheon M; Kwak YT
    Dement Neurocogn Disord; 2017 Sep; 16(3):57-63. PubMed ID: 30906372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [
    Zhao C; Liu C; Tang J; Xu Y; Xie M; Chen Z
    Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [
    Li J; Chen P; Bao Y; Sun Y; He J; Liu X
    Mol Imaging Biol; 2020 Oct; 22(5):1161-1169. PubMed ID: 31650482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.